Dr. Reddy launches Guaifenesin and Pseudoephedrine
Dr. Reddy launches Guaifenesin and Pseudoephedrine

Dr. Reddy launches Guaifenesin and Pseudoephedrine

Shohini Nath Article rating: 5.0

Dr. Reddy's Laboratories has launched an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended-Release Tablets in two strengths-Guaifenesin 600 mg and Pseudoephedrine HCI 60 mg, and Guaifenesin 1200 mg and Pseudoephedrine HCI 120 mg in the United States market, as approved by the US Food and Drug Administration (USFDA).


Technical Bits: Reliance forms bullish engulfing candle
Technical Bits: Reliance forms bullish engulfing candle

Technical Bits: Reliance forms bullish engulfing candle

Vinayak Gangule Article rating: 5.0

The stock of Reliance Industries formed bullish engulfing candle near upward sloping trendline support, which suggests bulls are taking control near the short-term support zone.

Zee Media: CARE downgrades credit rating
Zee Media: CARE downgrades credit rating

Zee Media: CARE downgrades credit rating

Gayathri Udyawar Article rating: 3.3

The stock of Zee Media was trailing by more than 3 per cent on Tuesday following an announcement that the company's Managing Director resigned and a downgrade of its credit ratings. 

Top 5 companies with change in promoter holding
Top 5 companies with change in promoter holding

Top 5 companies with change in promoter holding

Nidhi Jani Article rating: 2.6

Generally, if the promoter stake of a stock has increased, it provides a sign of confidence of the promoters in the business. On the other hand, if promoter stake has decreased, it is not at all a healthful sign.

RSS
First25162517251825192521252325242525Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR